Lung disease as a determinant of cognitive decline and dementia
Open accessThe DOI matches its Crossref record; 86 of the 89 references it cites were found in a registry or an index.
Abstract
Almost 40 million people currently live with dementia but this is estimated to double over the next 20 years; despite this, research identifying modifiable risk factors is scarce. There is increasing evidence that cognitive impairment is more frequent in those with chronic lung disease than those without. Chronic obstructive pulmonary disease affects 210 million people, with cognitive impairment present in 60% of certain populations. Co-morbid cognitive dysfunction also appears to impact on important outcomes such as quality of life, hospitalisation and survival. This review summarises the evidence of an association between cognition, impaired lung function and obstructive lung disease. It goes on to examine the contribution of neuro-imaging to our understanding of the underlying pathophysiology. While the mechanisms of brain pathology and cognitive impairment are likely to be complex and multi-factorial, there is evidence to suggest a key role for occult cerebrovascular damage independent of traditional vascular risk factors, including smoking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Risk factors for cognitive impairment in both general and chronic lung disease populations. This material has not been reviewed by the European Respiratory Society prior to release; therefore, the European Respiratory Society may not be responsible for any errors, omissions or inaccuracies, or for any consequences arising therefrom, in the content. Reproduced with permission of the European Respiratory Society [4].](https://figures.cochat.ai/paper-figures/f7d37ee9ffe04f1b875097d448b191bc/lung-disease-as-a-determinant-of-cognitive-decline-and-dementia-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other forms of cognitive dysfunction among individuals with advanced pulmonary disease may be amplified by hypoxemia or polypharmacy, and may improve post-transplant in some cases.(94–99)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [97]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of asthma: executive summary of the GINA Dissemination Committee Report
Masoli, M., Fabian, D., Holt, S., Beasley, R., & Program, G. I. F. A. (. (2004) · Allergy · doi:10.1111/j.1398-9995.2004.00526.x · Cited by 3,529
Global burden of COPD: risk factors, prevalence, and future trends
Mannino, D. M., & Buist, A. S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61380-4 · Cited by 2,079
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Mitchell, A. J., & Shiri‐Feshki, M. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01326.x · Cited by 1,659 · cited 1×
“Mild cognitive impairment (MCI) is associated with a 5 to 10% annual conversion rate to dementia [1,2].”
BackgroundLongstreth, W. T., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., Enright, P. L., O'Leary, D., & Fried, L. (1996) · Stroke · doi:10.1161/01.str.27.8.1274 · Cited by 1,464
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Mannino, D. M., Thorn, D., Swensen, A., & Holguin, F. (2008) · European Respiratory Journal · doi:10.1183/09031936.00012408 · Cited by 1,184
Grundman, M. (2004) · Archives of Neurology · doi:10.1001/archneur.61.1.59 · Cited by 972 · cited 1×
“Mild cognitive impairment (MCI) is associated with a 5 to 10% annual conversion rate to dementia [1,2].”
BackgroundMitchell, G. F. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.90549.2008 · Cited by 764
Smoking and Lung Function of Lung Health Study Participants after 11 Years
Anthonisen, N. R., Connett, J. E., & Murray, R. P. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2112096 · Cited by 697
Research works printed but not linked: 1
- Buckingham RJ, Lowe D, Pursey NA, Roberts CM, Stone RA. Report of the National Chronic Obstructive Pulmonary Disease Audit 2008: Clinical Audit of the COPD exacerbations admitted to acute NHS units across the UK. London: Royal College of Physicians - Clinical Effectiveness & Evaluation Unit, British Thoracic Society, British Lung Foundation; 2008.
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Gale, S. A., Acar, D., & Daffner, K. R. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.01.022 · Cited by 680
COVID-19 Artificial Intelligence Diagnosis Using Only Cough Recordings
Laguarta, J., Hueto, F., & Subirana, B. (2020) · IEEE Open Journal of Engineering in Medicine and Biology · doi:10.1109/ojemb.2020.3026928 · Cited by 589
Mumaw, C. L., Levesque, S., McGraw, C., Robertson, S., Lucas, S., Stafflinger, J. E., Campen, M. J., Hall, P., Norenberg, J. P., Anderson, T., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201500047 · Cited by 190
Measuring gait speed to better identify prodromal dementia
Grande, G., Triolo, F., Nuara, A., Welmer, A.-K., Fratiglioni, L., & Vetrano, D. L. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.05.014 · Cited by 184
“Cardiovascular and pulmonary diseases often co-occur and synergistically exert their detrimental effects virtually on every organ, system, and ultimately body function (Vetrano et al., 2018a; Qiu and Fratiglioni, 2015; Dodd, 2015; Yohannes et al., 2017).”
Metadata
- Authors
- Dodd, J. W.
- Affiliations
- Southmead Hospital (GB)
- Corresponding author
- Dodd, James W
- ORCID
- Dodd, James W
- Venue
- Alzheimer's Research & Therapy
- Published
- 2015-03-21
- Volume
- 7
- Issue
- 1
- Pages
- 32-32
- ISSN
- 1758-9193 (ISSN-L)
- PMC
- PMC4369069
- OpenAlex
- W2096205239
- Cited by
- 192
- References
- 89
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 19 · 2023: 17 · 2022: 26 · 2021: 17 · 2020: 20 · 2019: 12 · 2018: 16 · 2017: 9 · 2016: 9
- FWCI
- 9.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Alzheimer s Research & Therapy (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- National Institute for Health and Care Research (CL-2012-25-001)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- chronic obstructive pulmonary disease, cognitive impairment, dementia, cognitive decline, lung function, neuroimaging, cerebrovascular injury, smoking, modifiable risk factors, comorbidities
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lung disease as a determinant of cognitive decline and dementia. https://app.cochat.ai/papers/10.1186/s13195-015-0116-3
- The paper
- Dodd, J. W. (2015). Lung disease as a determinant of cognitive decline and dementia. Alzheimer's Research & Therapy. https://doi.org/10.1186/s13195-015-0116-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.